Abiopharma

News list

(99% Neutral) RADIUS HEALTH, INC. (RDUS) Announces Clinical Development Update

Full text

News bot Oct. 2, 2025, 5:29 a.m.
📋 RADIUS HEALTH, INC. (RDUS) - Clinical Trial Update

Filing Date: 2022-06-08

Accepted: 2022-06-08 08:39:41

Event Type: Clinical Trial Update
Event Details:
Radius Health Inc (the company was acquired by Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Sq (RDUS) Announces Clinical Trial Update Radius Health Inc (the company was acquired by Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Sq (RDUS) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: responsible, expected
Collaboration: Radius Health
expected by the end of 2022
anticipated in 2H 2022
expected in 2H 2022
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Radius Health Inc (the company was acquired by Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Sq
- CIK: 0001428522
- Ticker Symbol: RDUS
- Period End Date: 2022-06-02
- Document Type: 8-K